Skip NavigationSkip to Content
Staff | Frederick National Lab

Events

Defining Clinical Utility of Molecular Diagnostics for Cancer Treatment

View the event details below.

Calendar Add this event to your calendar

  1. Description: Many decisions for cancer patient management depend on information derived from clinical laboratory tests in addition to that derived from the clinical evaluation of these patients. At this workshop, participants will discuss and debate the definition of clinical utility for oncologic treatment, the evidence needed to demonstrate clinical utility for a molecular diagnostic, how that evidence should be obtained, and how NCI can best assist in the demonstration of clinical utility in the context of clinical trials. NCI will use this workshop to inform decisions about its role in this endeavor. The workshop format will be primarily interactive, with most of the time devoted to small focused breakout discussion groups. Please review the materials for your chosen breakout session under the Breakout Session Materials tab on this website before arriving at the workshop.
  2. Event Type: Conference
  3. Start time: 1/10/2013 at 8:00 AM    
  4. End time: 1/11/2013 at 12:00 PM
  5. Website: [N/A]
  6. VideoCast: [N/A]

Location

The campus and location are listed below.

  1. Campus: Bethesda
  2. Location: Building 45 Natcher, Main Auditorium

Series

The series is listed below.

  1. Series: [N/A]

Sponsors

If applicable, event sponsors are listed below.

No sponsors have been added to this event.

Speakers

If applicable, event speakers are listed below.

No speakers have been added to this event.

Contacts

If applicable, event contacts are listed below.

No contacts have been added to this event.

  • HHS Logo
  • NIH Logo
  • NCI Logo
  • USA.gov Logo